Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US

Overview of attention for article published in Neuropsychiatric Disease and Treatment, March 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,351 followers.

#Dalfampridine #ExtendedReleaseTablets: 1 year of #postmarketing #safety #experience in the #US: http://t.co/FNI1Y4HewK

Reply Repost Favourite